Presentation is loading. Please wait.

Presentation is loading. Please wait.

Todd C. Crawford, MD, J. Trent Magruder, MD, Joshua C

Published byΚύνθια Καραμανλής Modified over 5 years ago

Similar presentations

Presentation on theme: "Todd C. Crawford, MD, J. Trent Magruder, MD, Joshua C"— Presentation transcript:

1 Impaired Renal Function Should Not Be a Barrier to Transplantation in Patients With Cystic Fibrosis 
Todd C. Crawford, MD, J. Trent Magruder, MD, Joshua C. Grimm, MD, Alejandro Suarez-Pierre, MD, Xun Zhou, MD, Jinny S. Ha, MD, Robert S. Higgins, MD, Stephen R. Broderick, MD, Jonathan B. Orens, MD, Pali Shah, MD, Christian A. Merlo, MD, Bo S. Kim, MD, Errol L. Bush, MD  The Annals of Thoracic Surgery  Volume 104, Issue 4, Pages (October 2017) DOI: /j.athoracsur Copyright © 2017 The Society of Thoracic Surgeons Terms and Conditions

2 Fig 1 Kaplan-Meier survival analysis comparing survival out to 5 years after lung transplantation in patients with cystic fibrosis (CF) with and without pretransplantation renal dysfunction (PRD) (GFR ≤60 mL/min). (CI = confidence interval.) The Annals of Thoracic Surgery  , DOI: ( /j.athoracsur ) Copyright © 2017 The Society of Thoracic Surgeons Terms and Conditions

3 Fig 2 Kaplan-Meier analysis of graft survival at 5 years after lung transplantation in patients with cystic fibrosis (CF) with and without pretransplantation renal dysfunction (PRD) (GFR ≤60 mL/min). (CI = confidence interval.) The Annals of Thoracic Surgery  , DOI: ( /j.athoracsur ) Copyright © 2017 The Society of Thoracic Surgeons Terms and Conditions

4 Fig 3 Kaplan-Meier analysis comparing probability of prolonged hospitalization (>25 days) after lung transplantation in patients with CF with and without pretransplantation renal dysfunction (PRD) (GFR ≤60 mL/min). (CI = confidence interval.) The Annals of Thoracic Surgery  , DOI: ( /j.athoracsur ) Copyright © 2017 The Society of Thoracic Surgeons Terms and Conditions

5 Supplemental Figure 1 Multivariable logistic regression model identifying independent factors associated with 1-year mortality (left). Covariate hazard ratios with associated 95% confidence intervals displayed graphically (right). The Annals of Thoracic Surgery  , DOI: ( /j.athoracsur ) Copyright © 2017 The Society of Thoracic Surgeons Terms and Conditions

6 Supplemental Figure 2 Multivariable logistic regression model identifying independent factors associated with 3-year mortality (left). Covariate hazard ratios with associated 95% confidence intervals displayed graphically (right). The Annals of Thoracic Surgery  , DOI: ( /j.athoracsur ) Copyright © 2017 The Society of Thoracic Surgeons Terms and Conditions

7 Supplemental Figure 3 Multivariable logistic regression model identifying independent factors associated with 5-year survival (left). Covariate hazard ratios with associated 95% confidence intervals displayed graphically (right). The Annals of Thoracic Surgery  , DOI: ( /j.athoracsur ) Copyright © 2017 The Society of Thoracic Surgeons Terms and Conditions

Download ppt "Todd C. Crawford, MD, J. Trent Magruder, MD, Joshua C"

Similar presentations

Survival After Single Versus Bilateral Lung Transplantation for High-Risk Patients With Pulmonary Fibrosis  Eric S. Weiss, MD, MPH, Jeremiah G. Allen,

Survival After Single Versus Bilateral Lung Transplantation for High-Risk Patients With Pulmonary Fibrosis  Eric S. Weiss, MD, MPH, Jeremiah G. Allen,
Photodynamic Laser Therapy for Lesions in the Airway

Photodynamic Laser Therapy for Lesions in the Airway
Is Hospital Procedure Volume a Reliable Marker of Quality for Coronary Artery Bypass Surgery? A Comparison of Risk and Propensity Adjusted Operative and.

Is Hospital Procedure Volume a Reliable Marker of Quality for Coronary Artery Bypass Surgery? A Comparison of Risk and Propensity Adjusted Operative and.
Influence of diabetes on survival in patients with cystic fibrosis before and after lung transplantation  Don Hayes, MD, MS, Alpa V. Patel, MD, Sylvester.

Influence of diabetes on survival in patients with cystic fibrosis before and after lung transplantation  Don Hayes, MD, MS, Alpa V. Patel, MD, Sylvester.
What Predicts Long-Term Survival After Heart Transplantation

What Predicts Long-Term Survival After Heart Transplantation
Todd C. Crawford, MD, J. Trent Magruder, MD, Joshua C

Todd C. Crawford, MD, J. Trent Magruder, MD, Joshua C
Treating Constrictive Pericarditis in a Chinese Single-Center Study: A Five-Year Experience  Yiyun Lin, MD, Mi Zhou, MMS, Jian Xiao, MD, Bin Wang, MD,

Treating Constrictive Pericarditis in a Chinese Single-Center Study: A Five-Year Experience  Yiyun Lin, MD, Mi Zhou, MMS, Jian Xiao, MD, Bin Wang, MD,
Coronary Artery Bypass for Heart Failure in Ischemic Cardiomyopathy: 17-Year Follow- Up  Marco Pocar, MD, PhD, Andrea Moneta, MD, Adalberto Grossi, MD,

Coronary Artery Bypass for Heart Failure in Ischemic Cardiomyopathy: 17-Year Follow- Up  Marco Pocar, MD, PhD, Andrea Moneta, MD, Adalberto Grossi, MD,
Mauer Biscotti, MD, Whitney D

Mauer Biscotti, MD, Whitney D
Number of Lymph Nodes and Metastatic Lymph Node Ratio Are Associated With Survival in Lung Cancer  Chukwumere E. Nwogu, MD, Adrienne Groman, MA, Daniel.

Number of Lymph Nodes and Metastatic Lymph Node Ratio Are Associated With Survival in Lung Cancer  Chukwumere E. Nwogu, MD, Adrienne Groman, MA, Daniel.
Lung Transplant Mortality Is Improving in Recipients With a Lung Allocation Score in the Upper Quartile  Todd C. Crawford, MD, Joshua C. Grimm, MD, J.

Lung Transplant Mortality Is Improving in Recipients With a Lung Allocation Score in the Upper Quartile  Todd C. Crawford, MD, Joshua C. Grimm, MD, J.
Wenrui Ma, MD, Wei Zhang, MD, Wei Shi, MD, Ye Kong, MD, Xinyu Ma, MS 

Wenrui Ma, MD, Wei Zhang, MD, Wei Shi, MD, Ye Kong, MD, Xinyu Ma, MS 
Kanika Trehan, MD, Xun Zhou, MD, Stephen C. Yang, MD 

Kanika Trehan, MD, Xun Zhou, MD, Stephen C. Yang, MD 
Zhiqiang Xue, MD, Fengying Wu, MD, Karlyn E

Zhiqiang Xue, MD, Fengying Wu, MD, Karlyn E
Mortality Risk and Pulmonary Function in Adults With Cystic Fibrosis at Time of Wait Listing for Lung Transplantation  Don Hayes, MD, MS, Stephen Kirkby,

Mortality Risk and Pulmonary Function in Adults With Cystic Fibrosis at Time of Wait Listing for Lung Transplantation  Don Hayes, MD, MS, Stephen Kirkby,
Lisa M. Brown, MD, MAS, David T. Cooke, MD, Elizabeth A. David, MD 

Lisa M. Brown, MD, MAS, David T. Cooke, MD, Elizabeth A. David, MD 
Comparing Long-Term Survival Between Patients Undergoing Off-Pump and On-Pump Coronary Artery Bypass Graft Operations  Giovanni Filardo, PhD, MPH, Paul.

Comparing Long-Term Survival Between Patients Undergoing Off-Pump and On-Pump Coronary Artery Bypass Graft Operations  Giovanni Filardo, PhD, MPH, Paul.
Rika E. Ohkuma, MD, Todd C. Crawford, MD, Patricia M

Rika E. Ohkuma, MD, Todd C. Crawford, MD, Patricia M
The Impact of Peripheral Vascular Disease on Long-Term Survival After Coronary Artery Bypass Graft Surgery  Danny Chu, MD, Faisal G. Bakaeen, MD, Xing.

The Impact of Peripheral Vascular Disease on Long-Term Survival After Coronary Artery Bypass Graft Surgery  Danny Chu, MD, Faisal G. Bakaeen, MD, Xing.
Influence of Pulmonary Hypertension on Patients With Idiopathic Pulmonary Fibrosis Awaiting Lung Transplantation  Don Hayes, MD, MS, Sylvester M. Black,

Influence of Pulmonary Hypertension on Patients With Idiopathic Pulmonary Fibrosis Awaiting Lung Transplantation  Don Hayes, MD, MS, Sylvester M. Black,

Similar presentations

Ads by Google